In an era where societal and technological landscapes are rapidly evolving, governance systems face significant challenges in navigating the intricate domain of drug policy. Our recent study, “Developing strategic foresight for drug policy: trends, scenarios, and implications“, utilizes foresight analysis methodology to illuminate potential directions for Finland’s drug policy up to 2030. This study is part of the DRUG-PREP project, which has piloted strategic foresight in drug policy analysis in six European countries, and was carried out by the Finnish Institute for Health and Welfare. In this blog post, we briefly describe both the methodology we applied and the results obtained from our analysis...